News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
282,995 Results
Type
Article (14977)
Company Profile (299)
Press Release (267713)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (80150)
Career Advice (168)
Deals (13395)
Drug Delivery (39)
Drug Development (50830)
Employer Resources (32)
FDA (5887)
Job Trends (5185)
News (145657)
Policy (10122)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (930)
Accelerated approval (19)
Adcomms (14)
Allergies (81)
Alliances (21835)
ALS (124)
Alzheimer's disease (1031)
Antibody-drug conjugate (ADC) (241)
Approvals (6081)
Artificial intelligence (258)
Autoimmune disease (110)
Automation (9)
Bankruptcy (105)
Best Places to Work (4576)
BIOSECURE Act (6)
Biosimilars (101)
Biotechnology (230)
Bladder cancer (101)
Brain cancer (45)
Breast cancer (356)
Cancer (3146)
Cardiovascular disease (237)
Career advice (153)
Career pathing (7)
CAR-T (217)
CDC (5)
Cell therapy (563)
Cervical cancer (14)
Clinical research (43775)
Collaboration (1148)
Company closure (2)
Compensation (591)
Complete response letters (39)
COVID-19 (1102)
CRISPR (86)
C-suite (550)
Cystic fibrosis (112)
Data (4335)
Denatured (15)
Depression (92)
Diabetes (254)
Diagnostics (1387)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (10)
Drug discovery (187)
Drug pricing (49)
Drug shortages (3)
Duchenne muscular dystrophy (213)
Earnings (31802)
Editorial (25)
Employer branding (4)
Employer resources (30)
Events (51889)
Executive appointments (621)
FDA (7637)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (980)
Gene editing (182)
Generative AI (21)
Gene therapy (486)
GLP-1 (505)
Government (1155)
Grass and pollen (3)
Guidances (167)
Healthcare (6636)
HIV (18)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (190)
Immuno-oncology (39)
Indications (67)
Infectious disease (1206)
Inflammatory bowel disease (155)
Inflation Reduction Act (10)
Influenza (38)
Intellectual property (166)
Interviews (18)
IPO (7373)
IRA (12)
Job creations (869)
Job search strategy (135)
JPM (40)
Kidney cancer (9)
Labor market (22)
Layoffs (246)
Leadership (9)
Legal (1407)
Liver cancer (41)
Longevity (11)
Lung cancer (421)
Lymphoma (249)
Machine learning (24)
Management (7)
Manufacturing (375)
MASH (130)
Medical device (2685)
Medtech (2694)
Mergers & acquisitions (6648)
Metabolic disorders (724)
Multiple sclerosis (102)
NASH (13)
Neurodegenerative disease (229)
Neuropsychiatric disorders (71)
Neuroscience (1951)
Neurotech (1)
NextGen: Class of 2026 (2043)
Non-profit (871)
Now hiring (30)
Obesity (329)
Opinion (128)
Ovarian cancer (131)
Pain (104)
Pancreatic cancer (162)
Parkinson's disease (232)
Partnered (12)
Patents (302)
Patient recruitment (328)
Peanut (43)
People (26716)
Pharmaceutical (44)
Pharmacy benefit managers (7)
Phase 1 (15516)
Phase 2 (20325)
Phase 3 (12847)
Pipeline (3245)
Policy (91)
Postmarket research (858)
Preclinical (6566)
Press Release (31)
Prostate cancer (145)
Psychedelics (50)
Radiopharmaceuticals (238)
Rare diseases (647)
Real estate (1451)
Recruiting (12)
Regulatory (9934)
Reports (20)
Research institute (977)
Resumes & cover letters (18)
Rett syndrome (24)
RNA editing (21)
RSV (16)
Schizophrenia (124)
Series A (182)
Series B (135)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (119)
Sponsored (15)
Startups (2011)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (18)
The Weekly (62)
Vaccines (333)
Venture capital (69)
Weight loss (173)
Women's health (25)
Worklife (2)
Date
Today (6)
Last 7 days (344)
Last 30 days (1314)
Last 365 days (17872)
2026 (1654)
2025 (18140)
2024 (20601)
2023 (22521)
2022 (26922)
2021 (27888)
2020 (23460)
2019 (16309)
2018 (11803)
2017 (13813)
2016 (11916)
2015 (14427)
2014 (10465)
2013 (7543)
2012 (7612)
2011 (7697)
2010 (7522)
Location
Africa (156)
Alabama (65)
Alaska (2)
Arizona (71)
Arkansas (5)
Asia (18302)
Australia (3119)
California (7091)
Canada (1837)
China (774)
Colorado (246)
Connecticut (252)
Delaware (235)
Europe (39381)
Florida (903)
Georgia (210)
Hawaii (2)
Idaho (17)
Illinois (396)
India (35)
Indiana (160)
Iowa (8)
Japan (223)
Kansas (81)
Kentucky (10)
Louisiana (7)
Maine (11)
Maryland (737)
Massachusetts (5587)
Michigan (110)
Minnesota (249)
Mississippi (3)
Missouri (34)
Montana (16)
Nebraska (5)
Nevada (32)
New Hampshire (21)
New Jersey (1648)
New Mexico (13)
New York (1760)
North Carolina (827)
North Dakota (6)
Northern California (3479)
Ohio (178)
Oklahoma (11)
Oregon (24)
Pennsylvania (1276)
Puerto Rico (9)
Rhode Island (25)
South America (219)
South Carolina (9)
Southern California (2813)
Tennessee (41)
Texas (905)
United States (23366)
Utah (96)
Virginia (137)
Washington D.C. (37)
Washington State (593)
West Virginia (1)
Wisconsin (45)
282,995 Results for "intrinsic therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Intrinsic Therapeutics Announces the First Endoscopic Barricaid Implantation in the Great Lakes Region by Dr. Nick Nenadovich
November 17, 2025
·
2 min read
Press Releases
Intrinsic Therapeutics Announces the First Implantation of the Barricaid® Annular Closure Device Under Awake Sedation
September 3, 2025
·
2 min read
Press Releases
Intrinsic Therapeutics Announces the First Implantation of the Barricaid® Annular Closure Device via Endoscopic Approach
June 26, 2025
·
2 min read
Press Releases
Intrinsic Therapeutics Names Keith Valentine President and Chief Executive Officer
April 11, 2025
·
3 min read
Press Releases
Intrinsic Therapeutics, Inc. Announces That ISASS Has Issued Updated 2025 Recommendations and Coverage Criteria for Barricaid Bone-Anchored Annular Closure
June 20, 2025
·
3 min read
Press Releases
Peptone Establishes Strategic Partnership with Evotec to Selectively Target Intrinsically Disordered Proteins (IDPs) and Advance Small-Molecule Therapeutics at Scale
May 8, 2025
·
4 min read
Business
Dave Amerson and Tyler Binney Add Their Experience Commercializing Disruptive Technologies to Intrinsic Therapeutics’ Board of Directors
Intrinsic Therapeutics, Inc. announced the appointment of Dave Amerson and Tyler Binney to its Board of Directors.
February 13, 2024
·
2 min read
Press Releases
Peptone Announces Key Leadership Appointments to Progress Novel Protein Structural Insights for Intrinsically Disordered Protein-Driven Therapeutics
January 10, 2025
·
5 min read
Press Releases
NeuroEM Therapeutics(R) Appoints Dr. W. Scott Burgin as Chief Medical Officer
February 1, 2026
·
2 min read
Press Releases
Intrinsic Therapeutics Announces Changes in CMS’ 2025 Final Rule for Bone Anchored Annular Closure Resulting in Improved Payment for Hospital Outpatient and ASCs
November 12, 2024
·
2 min read
1 of 28,300
Next
